SPOTLIGHT -
Lutz Frolich, MD, PhD: Learning from Negative Trials
Lutz Frölich, MD, PhD, spoke about the importance of continuing with research in light of negative trials in Alzheimer disease.
Lutz Frolich, MD, PhD: Collaboration Between Clinicians and Industry
Lutz Frölich, MD, PhD, discussed the imperativeness of collaboration between stakeholders—clinicians, pharmaceutical companies, researchers—in developing therapies for Alzheimer disease.
Lutz Frolich, MD, PhD: Tempering Expectations for Alzheimer Disease Advancements
The head of the Department for Geriatric Psychiatry, Central Institute of Mental Health talked about the biggest challenges facing medicine in treating and understanding Alzheimer disease.
Lutz Frolich, MD, PhD: Target Patient Populations for Alzheimer Therapies
The head of the Department for Geriatric Psychiatry, Central Institute of Mental Health discussed his thoughts about patients with mild dementia and prodromal Alzheimer disease.
